Loading...

CSL Limited

CSL.AXASX
Healthcare
Biotechnology
A$270.90
A$-0.21(-0.08%)

CSL Limited (CSL.AX) Financial Performance & Income Statement Overview

Review CSL Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.

Revenue Growth
-24.99%
24.99%
Operating Income Growth
-57.73%
57.73%
Net Income Growth
-20.81%
20.81%
Operating Cash Flow Growth
-27.27%
27.27%
Operating Margin
20.83%
20.83%
Gross Margin
49.14%
49.14%
Net Profit Margin
18.41%
18.41%
ROE
15.37%
15.37%
ROIC
9.63%
9.63%

CSL Limited (CSL.AX) Income Statement & Financial Overview

Review CSL Limited's (CSL.AX) income statement with detailed quarterly and annual figures.

MetricQ2 2025Q4 2024Q2 2024Q4 2023
Revenue$8.21B$6.76B$8.36B$5.92B
Cost of Revenue$3.93B$3.68B$4.07B$3.29B
Gross Profit$4.28B$3.08B$4.29B$2.63B
Gross Profit Ratio$0.52$0.46$0.51$0.44
R&D Expenses$646.00M$769.94M$699.10M$647.34M
SG&A Expenses$1.18B$1.17B$903.61M$1.17B
Operating Expenses$4.28B$1.94B$1.60B$1.82B
Total Costs & Expenses$8.21B$5.62B$5.68B$5.10B
Interest Income$18.00M$19.25M$20.87M$3.24M
Interest Expense$213.00M$224.90M$265.03M$234.26M
Depreciation & Amortization$476.00M$515.66M$447.63M$441.88M
EBITDA$3.23B$1.75B$3.19B$1.36B
EBITDA Ratio$0.39$0.26$0.37$0.21
Operating Income$0.00$1.14B$2.69B$816.13M
Operating Income Ratio$0.00$0.17$0.32$0.14
Other Income/Expenses (Net)$2.54B-$132.71M-$204.51M-$128.29M
Income Before Tax$2.54B$1.009B$2.48B$687.84M
Income Before Tax Ratio$0.31$0.15$0.30$0.12
Income Tax Expense$484.00M$204.64M$478.94M$94.27M
Net Income$2.007B$750.69M$1.98B$593.56M
Net Income Ratio$0.24$0.11$0.24$0.10
EPS$4.15$2.33$4.11$1.23
Diluted EPS$4.13$2.32$4.09$1.22
Weighted Avg Shares Outstanding$483.25M$483.25M$482.83M$482.37M
Weighted Avg Shares Outstanding (Diluted)$485.75M$485.75M$484.98M$484.59M

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;